Human Investing’s Guardant Health GH Stock Holding History

Human Investing’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-10	Closed	-$2K	–	179
2021 Q1	$2K	Hold	10	–	–	﹤0.01%	281
2020 Q4	$1K	Hold	10	–	–	﹤0.01%	290
2020 Q3	$1K	Hold	10	–	–	﹤0.01%	292
2020 Q2	$1K	Hold	10	–	–	﹤0.01%	300
2020 Q1	$1K	Hold	10	–	–	﹤0.01%	291
2019 Q4	$1K	Hold	10	–	–	﹤0.01%	352
2019 Q3	$1K	Hold	10	–	–	﹤0.01%	338
2019 Q2	$1K	Sell	10 -10	-50%	-$764	﹤0.01%	331
2019 Q1	$2K	Buy	+20	New	+$1.11K	﹤0.01%	306

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Human Investing's GH Position: Q2 2021 in Review

Human Investing sold out of Guardant Health (GH) in Q2 2021, closing a stake of 10 shares — an estimated $2K sold.

Human Investing first reported a position in GH in Q1 2019 and held it in 9 quarters. The position peaked at $2K in Q1 2021. 417 funds tracked by Wall St. Rank hold GH as of Q2 2021.

Human Investing reported no remaining Guardant Health position as of Q2 2021 after selling out during the quarter.
Human Investing sold 10 Guardant Health shares in Q2 2021, an estimated $2K.
Human Investing first reported a position in Guardant Health in Q1 2019 and held it in 9 quarters.
Human Investing's Guardant Health position peaked at $2K in Q1 2021.
417 funds tracked by Wall St. Rank held Guardant Health as of Q2 2021.

Based on Human Investing's 13F filing for Q2 2021, filed 2 Aug 2021.